Literature DB >> 26169410

Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance in Klebsiella pneumoniae by zinc and copper pyrithione.

Kevin Chiem1, Brooke A Fuentes1, David L Lin1, Tung Tran1, Alexis Jackson1, Maria S Ramirez1, Marcelo E Tolmasky2.   

Abstract

The in vitro activity of the aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6')-Ib] was inhibited by CuCl2 with a 50% inhibitory concentration (IC50) of 2.8 μM. The growth of an amikacin-resistant Klebsiella pneumoniae strain isolated from a neonate with meningitis was inhibited when amikacin was supplemented by the addition of Zn(2+) or Cu(2+) in complex with the ionophore pyrithione. Coordination complexes between cations and ionophores could be developed for their use, in combination with aminoglycosides, to treat resistant infections.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26169410      PMCID: PMC4538519          DOI: 10.1128/AAC.01106-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis.

Authors:  M Woloj; M E Tolmasky; M C Roberts; J H Crosa
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

2.  Klebsiella pneumoniae sepsis with unusual cutaneous presentation of generalized pustulosis.

Authors:  H Y Huang; Y H Wu; C F Kuo
Journal:  Clin Exp Dermatol       Date:  2013-08       Impact factor: 3.470

Review 3.  Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.

Authors:  Elizabeth B Hirsch; Vincent H Tam
Journal:  J Antimicrob Chemother       Date:  2010-04-08       Impact factor: 5.790

4.  Septic arthritis subsequent to urosepsis caused by hypermucoviscous Klebsiella pneumoniae.

Authors:  Kei Suzuki; Akiko Nakamura; Tomoyuki Enokiya; Yoshiaki Iwashita; Eri Tomatsu; Yuichi Muraki; Toshihiro Kaneko; Masahiro Okuda; Naoyuki Katayama; Hiroshi Imai
Journal:  Intern Med       Date:  2013-07-15       Impact factor: 1.271

5.  Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models.

Authors:  J M Labaune; N Bleyzac; P Maire; R W Jelliffe; M J Boutroy; G Aulagner; G Putet
Journal:  Biol Neonate       Date:  2001-08

6.  Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-negatives: the Klebsiella pneumoniae Paradigm.

Authors:  Maria S Ramirez; German M Traglia; David L Lin; Tung Tran; Marcelo E Tolmasky
Journal:  Microbiol Spectr       Date:  2014

7.  Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.

Authors:  Aartjan J W te Velthuis; Sjoerd H E van den Worm; Amy C Sims; Ralph S Baric; Eric J Snijder; Martijn J van Hemert
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

8.  Complete nucleotide sequence of Klebsiella pneumoniae multiresistance plasmid pJHCMW1.

Authors:  Renee Sarno; Glen McGillivary; David J Sherratt; Luis A Actis; Marcelo E Tolmasky
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

9.  Rise and dissemination of aminoglycoside resistance: the aac(6')-Ib paradigm.

Authors:  María S Ramirez; Nikolas Nikolaidis; Marcelo E Tolmasky
Journal:  Front Microbiol       Date:  2013-05-17       Impact factor: 5.640

10.  Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010.

Authors:  Guillermo V Sanchez; Ronald N Master; Richard B Clark; Madiha Fyyaz; Padmaraj Duvvuri; Gupta Ekta; Jose Bordon
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

View more
  9 in total

1.  Amikacin in combination with zinc pyrithione prevents growth of a multidrug-resistant carbapenem-resistant Klebsiella pneumoniae isolate.

Authors:  Jesus Magallon; Peter Vu; Craig Reeves; Stella Kwan; Kimberly Phan; Crista L Oakley-Havens; María Soledad Ramirez; Marcelo E Tolmasky
Journal:  Int J Antimicrob Agents       Date:  2021-09-20       Impact factor: 15.441

2.  Identification of an Inhibitor of the Aminoglycoside 6'-N-Acetyltransferase type Ib [AAC(6')-Ib] by Glide Molecular Docking.

Authors:  Kevin Chiem; Saumya Jani; Brooke Fuentes; David L Lin; Madeline E Rasche; Marcelo E Tolmasky
Journal:  Medchemcomm       Date:  2015-11-03       Impact factor: 3.597

3.  Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes.

Authors:  Alexis Jackson; Saumya Jani; Carol Davies Sala; Alfonso J C Soler-Bistué; Angeles Zorreguieta; Marcelo E Tolmasky
Journal:  Biol Methods Protoc       Date:  2016-03-01

Review 4.  Amikacin: Uses, Resistance, and Prospects for Inhibition.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

5.  Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc.

Authors:  Jesus Magallon; Kevin Chiem; Tung Tran; Maria S Ramirez; Veronica Jimenez; Marcelo E Tolmasky
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

6.  Retention of antibiotic activity against resistant bacteria harbouring aminoglycoside-N-acetyltransferase enzyme by adjuvants: a combination of in-silico and in-vitro study.

Authors:  Shamim Ahmed; Sabrina Amita Sony; Md Belal Chowdhury; Md Mahib Ullah; Shatabdi Paul; Tanvir Hossain
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

7.  Aminoglycoside 6'-N-acetyltransferase Type Ib [AAC(6')-Ib]-Mediated Aminoglycoside Resistance: Phenotypic Conversion to Susceptibility by Silver Ions.

Authors:  Craig M Reeves; Jesus Magallon; Kenneth Rocha; Tung Tran; Kimberly Phan; Peter Vu; Yang Yi; Crista L Oakley-Havens; José Cedano; Verónica Jimenez; Maria S Ramirez; Marcelo E Tolmasky
Journal:  Antibiotics (Basel)       Date:  2020-12-31

8.  Amikacin potentiator activity of zinc complexed to a pyrithione derivative with enhanced solubility.

Authors:  Jesus Magallon; Peter Vu; Craig Reeves; Stella Kwan; Kimberly Phan; Crista L Oakley-Havens; Kenneth Rocha; Veronica Jimenez; María Soledad Ramirez; Marcelo E Tolmasky
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

9.  Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China.

Authors:  Zhijian Zhang; Wei Wang; Yufeng Wang; Zhongtan Xue; Shanshan Li; Yu Pang
Journal:  Infect Drug Resist       Date:  2022-04-28       Impact factor: 4.177

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.